Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

BioCina is derived from “Bio” being the prefix of Biotech, and “Cina” being the suffix to Medicina, Italian for medicine or drug. BioCina has a strong history as a multi-product biologics contract development and manufacturing organization (CDMO), focused on development and cGMP manufacture of microbial-based therapeutics, from preclinical to commercial production. The site, approved by the FDA for commercial manufactu...
BioCina is derived from “Bio” being the prefix of Biotech, and “Cina” being the suffix to Medicina, Italian for medicine or drug. BioCina has a strong history as a multi-product biologics contract development and manufacturing organization (CDMO), focused on development and cGMP manufacture of microbial-based therapeutics, from preclinical to commercial production. The site, approved by the FDA for commercial manufacturing in 2020, has 35+ years of microbial fermentation experience and over the past 15 years, has worked on over 50 different products and has partnered with more than 30 customers globally.

List your booth number for exhibitions, ask us